24 Jan 2024 | 04:00 PM GMT

Scientific Exchange

Participants:

AM
Abdelali Majdi OtherBayer
AM
Abdelali Majdi
OtherBayer
AS
Albrecht Stenzinger OtherHeidelberg University Hospital
AS
Albrecht Stenzinger
OtherHeidelberg University Hospital
Andrew Norden Chief Medical OfficerOncoHealth
Andrew Norden
Chief Medical OfficerOncoHealth
Anne Bruinvels FounderPx HealthCare
Anne Bruinvels
FounderPx HealthCare
Arndt Schmitz Medical Software Product LeadBayer AG
Arndt Schmitz
Medical Software Product LeadBayer AG
Chandana Fitzgerald President, CommunityHLTH
Chandana Fitzgerald
President, CommunityHLTH
Christina Kotsi Innovation Lead, Global Medical & EvidenceBayer
Christina Kotsi
Innovation Lead, Global Medical & EvidenceBayer
Dr Saad Chief Medical OfficerOncoclínicas Precision Medicine
Dr Saad
Chief Medical OfficerOncoclínicas Precision Medicine
Ethan BaschChief of OncologyUniversity of North Carolina
US Council
Ethan Basch
US Council
Chief of OncologyUniversity of North Carolina
FM
Finlay McDougall Senior Principal, EMEA Real World Solutions Medical Evidence PracticeIQVIA
FM
Finlay McDougall
Senior Principal, EMEA Real World Solutions Medical Evidence PracticeIQVIA
FV
Frank Verholen OtherBayer
FV
Frank Verholen
OtherBayer
Garima Sharma Community Manager HealthXL
Garima Sharma
Community Manager HealthXL
JM Theagene President360Medlink
JM Theagene
President360Medlink
KM
Krishna Moorthy FounderAlvie Health
KM
Krishna Moorthy
FounderAlvie Health
Krishna Moorthy Senior Lecturer, Consultant SurgeonImperial College London
Krishna Moorthy
Senior Lecturer, Consultant SurgeonImperial College London
Lynda Chin Co-Founder, President and CEOApricity
Lynda Chin
Co-Founder, President and CEOApricity
Maike Schmitz Oncology LeadRoX Health GmbH
Maike Schmitz
Oncology LeadRoX Health GmbH
RB
Ravi B. Parikh Oncologist and Faculty Member at PennUniversity of Pennsylvania
RB
Ravi B. Parikh
Oncologist and Faculty Member at PennUniversity of Pennsylvania
SK
Svetlana Kobina OtherBayer
SK
Svetlana Kobina
OtherBayer
Tessy Huss Director of Strategy , HLTH CommunityHLTH Community
Tessy Huss
Director of Strategy , HLTH CommunityHLTH Community
Vanessa Quintero Real World Evidence OncologyBayer
Vanessa Quintero
Real World Evidence OncologyBayer
YZ
Yousuf Zafar Senior VP, Medical InformaticsOptum
YZ
Yousuf Zafar
Senior VP, Medical InformaticsOptum

About this Meeting

While the potential of digital health in Oncology remains untapped, advancements indicate promising avenues for integrating digital tools in cancer care. 


Evidence suggests that electronic patient-reported outcomes (ePROs), for instance, contribute to improved symptom identification and symptom management. Additionally, the use of wearables in monitoring health-related data has demonstrated a positive impact on physical activity and quality of life.


Pharmaceutical companies find themselves re-evaluating the ‘traditional’ patient journey, continuously reassessing how technology can and should be deployed to gather deeper insights, enhance treatment experiences, and improve outcomes. 


Join this roundtable discussion hosted by Bayer, inviting experts, healthcare providers, and digital health innovators to engage in a conversation about leveraging digital tools to enhance patient experiences, refine disease management strategies, and enable data-driven decision-making in cancer care.


We would like to remind you that our meetings are small and intimate sessions with a limited number of seats available, therefore we rely on your attendance and participation to ensure a high quality and valuable meeting for all. If you are confirmed for this meeting we ask if you can please ensure your attendance on the day.